Danaher Corporation names Matthew Gugino as CFO

Danaher Corporation (NYSE: DHR) announced the appointment of Matthew Gugino as Chief Financial Officer, effective February 28, 2026. Gugino, who currently serves as Group Chief Financial Officer of the Life Sciences Innovations Group, will succeed Matthew McGrew. McGrew will transition to the role of Executive Vice President and will begin a gradual retirement process after more than 20 years with the company.

President and CEO Rainer Blair highlighted McGrew's contributions to Danaher, noting his key involvement in strategic acquisitions and company growth initiatives. “Matt McGrew's financial leadership over the past two decades has been instrumental in shaping the Danaher you see today,” Blair said.

Looking ahead, Blair emphasized Gugino's readiness for the CFO role, citing his broad expertise in financial planning, Mergers and Acquisitions (M&A), and talent development. “Matt has been instrumental in shaping our financial strategy and portfolio evolution,” Blair noted.

Gugino joined Danaher in 2013 as Director of Investor Relations and has held various finance leadership roles within the company, including Vice President of Financial Planning & Analysis since 2019 and Group CFO since 2021. His background also includes positions at Barclays and Morgan Stanley, complementing his extensive experience in corporate finance.